mitoxantrone has been researched along with Neoplasms, Bone Marrow in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Girsberger, S | 1 |
| Karow, A | 1 |
| Lundberg, P | 1 |
| Dirnhofer, S | 1 |
| Lehmann, T | 1 |
| Passweg, JR | 1 |
| Tichelli, A | 1 |
| Skoda, R | 1 |
| Rovó, A | 1 |
1 other study available for mitoxantrone and Neoplasms, Bone Marrow
| Article | Year |
|---|---|
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
Topics: Alleles; Antineoplastic Agents; Bone Marrow Neoplasms; Drug Therapy, Combination; Etoposide; Humans; | 2013 |